Development_NN of_IN a_DT Real-Time_JJ Reverse_NP Transcriptase_NP PCR_NP Assay_NP for_IN Type_NP A_NP Influenza_NP Virus_NP and_CC the_DT Avian_NP H5_NP and_CC H7_NP Hemagglutinin_NP Subtypes_VBZ A_DT real-time_JJ reverse_NN transcriptase_NN PCR_NP (_( RRT-PCR_NP )_) assay_NN based_VBN on_IN the_DT avian_JJ influenza_NN virus_NN matrix_NN gene_NN was_VBD developed_VBN for_IN the_DT rapid_JJ detection_NN of_IN type_NN A_DT influenza_NN virus_NN ._SENT Additionally_RB ,_, H5_NP and_CC H7_JJ hemagglutinin_NN subtype-specific_JJ probe_NN sets_NNS were_VBD developed_VBN based_VBN on_IN North_NP American_NP avian_JJ influenza_NN virus_NN sequences_NNS ._SENT The_DT RRT-PCR_NP assay_NN utilizes_VBZ a_DT one-step_NN RT-PCR_NP protocol_NN and_CC fluorogenic_JJ hydrolysis_NN type_NN probes_NNS ._SENT The_DT matrix_NN gene_NN RRT-PCR_NP assay_NN has_VBZ a_DT detection_NN limit_NN of_IN 10_CD fg_NN or_CC approximately_RB 1,000_CD copies_NNS of_IN target_NN RNA_NP and_CC can_MD detect_VB 0.1_CD 50_CD %_NN egg_NN infective_JJ dose_NN of_IN virus_NN ._SENT The_DT H5-_NP and_CC H7-specific_NP probe_NN sets_VBZ each_DT have_VBP a_DT detection_NN limit_NN of_IN 100_CD fg_NN of_IN target_NN RNA_NP or_CC approximately_RB 103_CD to_TO 104_CD gene_NN copies_NNS ._SENT The_DT sensitivity_NN and_CC specificity_NN of_IN the_DT real-time_JJ PCR_NP assay_NN were_VBD directly_RB compared_VBN with_IN those_DT of_IN the_DT current_JJ standard_NN for_IN detection_NN of_IN influenza_NN virus_NN :_: virus_NN isolation_NN (_( VI_CD )_) in_IN embryonated_JJ chicken_NN eggs_NNS and_CC hemagglutinin_NN subtyping_NN by_IN hemagglutination_NN inhibition_NN (_( HI_NP )_) assay_NN ._SENT The_DT comparison_NN was_VBD performed_VBN with_IN 1,550_CD tracheal_JJ and_CC cloacal_JJ swabs_NNS from_IN various_JJ avian_JJ species_NNS and_CC environmental_JJ swabs_NNS obtained_VBN from_IN live-bird_NN markets_NNS in_IN New_NP York_NP and_CC New_NP Jersey_NP ._SENT Influenza_NN virus-specific_JJ RRT-PCR_NP results_NNS correlated_VBD with_IN VI_CD results_NNS for_IN 89_CD %_NN of_IN the_DT samples_NNS ._SENT The_DT remaining_VBG samples_NNS were_VBD positive_JJ with_IN only_RB one_CD detection_NN method_NN ._SENT Overall_RB the_DT sensitivity_NN and_CC specificity_NN of_IN the_DT H7-_NP and_CC H5-specific_NP RRT-PCR_NP were_VBD similar_JJ to_TO those_DT of_IN VI_NP and_CC HI_NP ._SENT Highly_RB pathogenic_JJ strains_NNS of_IN avian_JJ influenza_NN virus_NN (_( AIV_NP )_) ,_, which_WDT are_VBP type_NN A_DT influenza_NN viruses_NNS ,_, cause_VB severe_JJ disease_NN in_IN domestic_JJ poultry_NN ,_, including_VBG chickens_NNS and_CC turkeys_NNS ._SENT Because_IN of_IN the_DT high_JJ morbidity_NN and_CC mortality_NN associated_VBN with_IN highly_RB pathogenic_JJ AIV_NP ,_, infection_NN of_IN commercial_JJ poultry_NN can_MD lead_VB to_TO substantial_JJ economic_JJ losses_NNS as_IN demonstrated_VBN by_IN the_DT 1983_CD to_TO 1984_CD outbreak_NN in_IN Pennsylvania_NP ._SENT Highly_RB pathogenic_JJ AIV_NP is_VBZ considered_VBN to_TO be_VB exotic_JJ to_TO the_DT United_NP States_NPS ,_, although_IN low_JJ pathogenic_JJ AIV_NP is_VBZ routinely_RB isolated_VBN from_IN turkeys_NNS reared_VBN in_IN migratory_JJ bird_NN flyways_NNS in_IN the_DT midwest_NN and_CC from_IN various_JJ avian_JJ species_NNS in_IN live-bird_NN markets_NNS in_IN New_NP York_NP and_CC New_NP Jersey_NP ._SENT The_DT AIVs_NP currently_RB circulating_VBG in_IN the_DT live-bird_NN markets_NNS of_IN New_NP York_NP and_CC New_NP Jersey_NP have_VBP been_VBN classified_VBN as_IN low_RB pathogenic_JJ ._SENT However_RB ,_, previous_JJ epornitics_NNS of_IN highly_RB pathogenic_JJ AIV_NP have_VBP occurred_VBN in_IN regions_NNS where_WRB low_JJ pathogenic_JJ AIV_NP had_VBD increased_VBN in_IN pathogenicity_NN after_IN circulating_VBG in_IN the_DT poultry_NN population_NN for_IN a_DT period_NN of_IN time_NN ._SENT Historically_RB ,_, highly_RB pathogenic_JJ AIVs_NNS in_IN poultry_NN have_VBP only_RB belonged_VBN to_TO the_DT H5_NP and_CC H7_JJ hemagglutinin_NN (_( HA_NP )_) subtypes_NNS ._SENT Therefore_RB ,_, because_IN there_EX is_VBZ a_DT greater_JJR risk_NN for_IN these_DT subtypes_NNS to_TO become_VB highly_RB pathogenic_JJ ,_, it_PP is_VBZ important_JJ to_TO identify_VB them_PP specifically_RB in_IN surveillance_NN programs_NNS ._SENT Currently_RB ,_, virus_NN isolation_NN (_( VI_CD )_) in_IN embryonating_JJ chicken_NN eggs_NNS and_CC subsequent_JJ HA_NP and_CC neuraminidase_NN subtyping_NN by_IN serological_JJ methods_NNS constitute_VBP the_DT standard_NN for_IN AIV_NP detection_NN and_CC subtype_NN identification_NN ._SENT Although_IN VI_CD in_IN embryonating_JJ eggs_NNS is_VBZ a_DT sensitive_JJ method_NN ,_, it_PP may_MD take_VB 1_CD to_TO 2_CD weeks_NNS to_TO obtain_VB results_NNS ,_, by_IN which_WDT time_NN the_DT results_NNS may_MD no_RB longer_RBR be_VB relevant_JJ ._SENT Conversely_RB real-time_JJ reverse_JJ transcriptase_NN PCR_NP (_( RRT-PCR_NP )_) can_MD be_VB a_DT rapid_JJ assay_NN ;_: results_NNS ,_, including_VBG subtyping_NN ,_, may_MD be_VB available_JJ in_IN less_JJR than_IN 1_CD day_NN ._SENT It_PP can_MD also_RB be_VB less_RBR expensive_JJ on_IN a_DT cost-per-sample_JJ basis_NN than_IN VI_CD in_IN embryonating_JJ eggs_NNS ._SENT Standard_NP RT-PCR_NP has_VBZ been_VBN previously_RB applied_VBN to_TO the_DT detection_NN of_IN avian_JJ influenza_NN virus_NN and_CC each_DT of_IN the_DT 15_CD HA_NP subtypes_NNS ._SENT Additionally_RB ,_, an_DT RRT-PCR_NP assay_NN for_IN influenza_NN virus_NN has_VBZ been_VBN developed_VBN ;_: however_RB ,_, it_PP is_VBZ a_DT two-step_JJ RT-PCR_NP ,_, multiplex_JJ assay_NN based_VBN on_IN human_JJ influenza_NN virus_NN sequences_NNS for_IN the_DT detection_NN of_IN influenza_NN virus_NN types_NNS A_NP and_CC B_NP ._SENT One-step_NN RRT-PCR_NP with_IN hydrolysis_NN probes_NNS ,_, as_RB described_VBN by_IN Holland_NP et_FW al._FW and_CC Livak_NN et_FW al._FW ,_, has_VBZ been_VBN successfully_RB applied_VBN to_TO the_DT detection_NN of_IN various_JJ RNA_NP viruses_NNS ._SENT RRT-PCR_NP offers_VBZ the_DT advantages_NNS of_IN speed_NN and_CC no_DT post-PCR_NP sample_NN handling_NN ,_, thus_RB reducing_VBG the_DT chance_NN for_IN cross-contamination_NN versus_IN standard_JJ RT-PCR_NP ._SENT In_IN this_DT study_NN we_PP describe_VBP the_DT development_NN of_IN a_DT one-step_NN RRT-PCR_NP assay_NN with_IN hydrolysis_NN type_NN probes_NNS for_IN the_DT rapid_JJ screening_NN of_IN clinical_JJ samples_NNS and_CC live-bird_NN markets_NNS for_IN type_NN A_DT influenza_NN virus_NN and_CC for_IN the_DT subsequent_JJ identification_NN of_IN the_DT H5_NP and_CC H7_JJ avian_JJ influenza_NN virus_NN subtypes_NNS ._SENT RNA_NP extraction_NN ._SENT |_SYM RNA_NP was_VBD extracted_VBN with_IN the_DT RNeasy_NP kit_NN (_( Qiagen_NP ,_, Valencia_NP ,_, Calif._NP )_) with_IN a_DT modified_JJ protocol_NN for_IN fluid_JJ samples_NNS recommended_VBN by_IN the_DT manufacturer_NN ._SENT Briefly_RB ,_, 500_CD mul_NN of_IN swab_NN material_NN from_IN clinical_JJ samples_NNS was_VBD clarified_VBN by_IN centrifugation_NN at_IN 12,000_CD x_NN g_NN for_IN 2_CD min_NN ,_, or_CC ,_, for_IN previously_RB isolated_VBN viruses_NNS ,_, 500_CD mul_NN of_IN chorioallantoic_JJ fluid_NN (_( CAF_NP )_) was_VBD mixed_VBN with_IN 500_CD mul_NN of_IN 70_CD %_NN ethanol_NN and_CC 500_CD mul_NN of_IN kit-supplied_JJ RLT_NP buffer_NN (_( Qiagen_NP )_) and_CC the_DT entire_JJ sample_NN was_VBD applied_VBN to_TO the_DT RNeasy_NP spin_NN column_NN ._SENT Subsequently_RB the_DT kit_NN protocol_NN for_IN RNA_NP isolation_NN from_IN the_DT cytoplasm_NN of_IN cells_NNS was_VBD followed_VBN ._SENT RNA_NP was_VBD eluted_VBN in_IN 50_CD mul_NN of_IN nuclease-free_JJ water_NN ,_, and_CC 8_CD mul_NN per_IN RRT-PCR_NP was_VBD used_VBN for_IN the_DT template_NN ._SENT Hydrolysis_NN probe_NN and_CC primer_NN sets_NNS ._SENT |_SYM An_DT influenza_NN virus_NN matrix_NN gene-specific_NP PCR_NP primer_NN set_NN and_CC hydrolysis_NN probe_NN were_VBD designed_VBN for_IN a_DT region_NN conserved_VBN in_IN all_DT type_NN A_DT influenza_NN virus_NN matrix_NN genes_NNS ._SENT In_IN addition_NN ,_, H5-_NP and_CC H7-specific_NP primer_NN sets_VBZ for_IN conserved_VBN regions_NNS of_IN the_DT H5_NP and_CC H7_NP HA_NP gene_NN sequences_NNS were_VBD developed_VBN ._SENT However_RB ,_, because_IN of_IN the_DT large_JJ sequence_NN variation_NN of_IN the_DT H5_NP and_CC H7_JJ genes_NNS ,_, the_DT probes_NNS and_CC primers_NNS were_VBD primarily_RB targeted_VBN to_TO North_NP American_NP H5_NP and_CC H7_JJ influenza_NN viruses_NNS ._SENT All_DT probes_NNS were_VBD labeled_VBN at_IN the_DT 5_CD '_POS end_NN with_IN the_DT 6-carboxyfluorescein_NP (_( FAM_NP )_) reporter_NN dye_NN and_CC at_IN the_DT 3_CD '_POS end_NN with_IN the_DT 6-carboxytetramethylrhodamine_JJ (_( TAMRA_NP )_) quencher_NN dye_NN ._SENT RRT-PCR_NP ._SENT |_SYM The_DT Qiagen_NP one-step_NN RT-PCR_NP kit_NN was_VBD used_VBN with_IN a_DT 20-mul_JJ reaction_NN mixture_NN under_IN the_DT following_VBG conditions_NNS :_: 0.8_CD mul_NN of_IN kit-supplied_JJ enzyme_NN mixture_NN (_( including_VBG RT_NP and_CC hot-start_NP Taq_NP polymerase_NN )_) ,_, 10_CD pmol_NN of_IN each_DT primer_NN ,_, 0.3_CD muM_NN probe_NN ,_, 400_CD muM_NN (_( each_DT )_) deoxynucleoside_NN triphosphate_NN ,_, 3.75_CD mM_NP MgCl2_NP ,_, and_CC 6.5_CD U_NN of_IN RNase_NP inhibitor_NN (_( Promega_NP ,_, Madison_NP ,_, Wis._NP )_) ._SENT The_DT RT_NP step_NN conditions_NNS for_IN all_DT primer_NN sets_NNS were_VBD 30_CD min_NN at_IN 50C_NP and_CC 15_CD min_NN at_IN 94C_NN ._SENT A_DT two-step_JJ PCR_NP cycling_NN protocol_NN was_VBD used_VBN for_IN the_DT matrix_NN gene_NN primer_NN set_NN as_RB follows_VBZ :_: 45_CD cycles_NNS of_IN 94C_NN for_IN 0_CD s_NNS and_CC 60C_JJ for_IN 20_CD s._NN The_DT H7_JJ PCR_NP cycling_NN conditions_NNS were_VBD the_DT same_JJ as_IN those_DT for_IN the_DT matrix_NN gene_NN except_IN that_WDT a_DT 58C_NN annealing_VBG temperature_NN was_VBD used_VBN for_IN 40_CD cycles_NNS ._SENT A_DT three-step_NN cycling_NN protocol_NN was_VBD used_VBN for_IN the_DT H5-specific_NP PCR_NP as_RB follows_VBZ :_: 94C_NN for_IN 0_CD s_NNS ,_, 57C_NN for_IN 20_CD s_NNS ,_, and_CC 72C_NP for_IN 5_CD s_NNS for_IN 40_CD cycles_NNS ._SENT All_DT temperature_NN transition_NN rates_NNS were_VBD set_VBN at_IN the_DT maximum_JJ transition_NN rate_NN of_IN 20_CD ._SENT Fluorescence_NN data_NNS were_VBD acquired_VBN at_IN the_DT end_NN of_IN each_DT annealing_VBG step_NN ._SENT RRT-PCR_NP was_VBD performed_VBN with_IN the_DT ruggedized_VBN advanced_JJ pathogen_NN identification_NN device_NN (_( RAPID_NP )_) thermocycler_NN (_( a_DT rapid_JJ air_NN thermocycler_NN )_) and_CC software_NN (_( Idaho_NP Technologies_NP ,_, Salt_NP Lake_NP City_NP ,_, Utah_NP )_) ._SENT Positive_JJ and_CC negative_JJ results_NNS of_IN RRT-PCRs_NP were_VBD determined_VBN by_IN the_DT RAPID_NP autoanalysis_NN software_NN and_CC rechecked_VBD manually_RB ._SENT Specificity_NN of_IN primer_NN and_CC probe_NN sets_NNS ._SENT |_SYM RRT-PCR_NP with_IN the_DT matrix_NN gene_NN primer_NN and_CC probe_NN set_NN was_VBD performed_VBN with_IN template_NN RNA_NP from_IN influenza_NN virus_NN isolates_VBZ representing_VBG all_DT HA_NP subtypes_NNS (_( see_VB Table_NP )_) including_VBG both_DT avian_JJ North_NP American_NP and_CC Eurasian_JJ lineage_NN viruses_NNS and_CC isolates_NNS of_IN human_JJ ,_, equine_JJ ,_, and_CC swine_NN origin_NN to_TO demonstrate_VB specificity_NN for_IN type_NN A_DT influenza_NN virus_NN ._SENT RRT-PCR_NN with_IN the_DT H5_NP and_CC H7_JJ subtype-specific_JJ probe_NN sets_NNS was_VBD also_RB performed_VBN with_IN template_NN RNA_NP from_IN all_DT HA_NP subtypes_NNS listed_VBN in_IN Table_NP to_TO demonstrate_VB specificity_NN for_IN their_PP$ respective_JJ subtypes_NNS ._SENT In_IN vitro_NN transcription_NN ._SENT |_SYM In_IN vitro-transcribed_JJ matrix_NN ,_, H5_NP ,_, or_CC H7_JJ gene_NN RNA_NP was_VBD used_VBN for_IN positive_JJ controls_NNS and_CC for_IN the_DT determination_NN of_IN the_DT detection_NN limits_VBZ of_IN the_DT assay_NN ._SENT The_DT influenza_NN H5_NP and_CC H7_NP HA_NP genes_NNS and_CC the_DT matrix_NN gene_NN which_WDT had_VBD been_VBN cloned_VBN into_IN the_DT pAMP1_JJ vector_NN (_( Life_NP Technologies_NP ,_, Rockville_NP ,_, Md._NP )_) as_IN previously_RB described_VBN were_VBD transcribed_VBN with_IN the_DT RiboMax_NP (_( Promega_NP )_) kit_NN from_IN the_DT T7_JJ promoter_NN in_IN accordance_NN with_IN the_DT kit_NN instructions_NNS and_CC quantitated_VBN by_IN spectrophotometer_NN ._SENT Sequencing_NP ._SENT |_SYM The_DT entire_JJ matrix_NN gene_NN from_IN six_CD samples_NNS which_WDT were_VBD negative_JJ by_IN the_DT RRT-PCR_NP assay_NN and_CC positive_JJ by_IN VI_NP and_CC another_DT six_CD samples_NNS which_WDT were_VBD positive_JJ by_IN RRT-PCR_NP and_CC VI_NP during_IN the_DT original_JJ testing_NN were_VBD amplified_VBN by_IN standard_JJ RT-PCR_NP with_IN the_DT Qiagen_NP one-step_NN kit_NN ,_, and_CC primers_NNS were_VBD directed_VBN to_TO the_DT 12_CD or_CC 13_CD conserved_VBN bases_NNS at_IN the_DT ends_NNS of_IN each_DT influenza_NN virus_NN RNA_NP segment_NN ._SENT The_DT amplicons_NNS were_VBD subsequently_RB excised_VBN from_IN the_DT gel_NN and_CC extracted_VBN with_IN the_DT Qiagen_NP gel_NN extraction_NN kit_NN ._SENT If_IN no_DT amplicon_NN was_VBD visible_JJ ,_, bands_NNS at_IN the_DT appropriate_JJ size_NN on_IN the_DT gel_NN were_VBD excised_VBN and_CC extracted_VBN from_IN the_DT gel_NN ._SENT Products_NNS of_IN the_DT gel_NN extraction_NN were_VBD cloned_VBN into_IN the_DT pAMP1_JJ vector_NN (_( Life_NP Technologies_NPS )_) as_RB previously_RB described_VBN ._SENT Sequencing_NP was_VBD performed_VBN with_IN the_DT ABI_NP BigDye_NP terminator_NN system_NN (_( Applied_NP Biosystems_NP ,_, Foster_NP City_NP ,_, Calif._NP )_) ._SENT Embryo_NN titration_NN ._SENT |_SYM Virus_NP was_VBD diluted_VBN in_IN brain_NN heart_NN infusion_NN broth_NN with_IN 10,000_CD IU_NP of_IN penicillin_NN G_NP ,_, 2,000_CD mug_NN of_IN streptomycin_NN ,_, 1,000_CD mug_NN of_IN gentamicin_NN ,_, 650_CD mug_NN of_IN kanamycin_NN ,_, and_CC 20_CD mug_NN of_IN amphotericin_NP B/ml_NP ._SENT Fertile_JJ chicken_NN eggs_NNS were_VBD inoculated_VBN with_IN 100_CD mul_NN of_IN virus_NN at_IN 10_CD days_NNS of_IN incubation_NN by_IN the_DT chorioallantoic_JJ sac_NN route_NN ._SENT Five_CD eggs_NNS were_VBD inoculated_VBN per_IN dilution_NN ._SENT At_IN 7_CD days_NNS postinoculation_NN CAF_NP was_VBD collected_VBN and_CC tested_VBN for_IN hemagglutination_NN with_IN 0.5_CD %_NN chicken_NN red_JJ blood_NN cells_NNS (_( CRBCs_NP )_) in_IN phosphate-buffered_JJ saline_NN ._SENT The_DT virus_NN titer_NN was_VBD determined_VBN by_IN the_DT Reed-Meunch_NP method_NN ._SENT RNA_NP for_IN RRT-PCR_NP was_VBD extracted_VBN from_IN the_DT virus_NN dilutions_NNS at_IN the_DT time_NN of_IN egg_NN inoculation_NN with_IN the_DT RNeasy_NP kit_NN (_( Qiagen_NP )_) as_IN previously_RB described_VBN ._SENT Comparison_NN with_IN VI_CD in_IN embryonating_JJ chicken_NN eggs_NNS ._SENT |_SYM Fifteen_NP hundred_CD fifty_CD swab_NN samples_NNS were_VBD obtained_VBN from_IN the_DT live-bird_NN markets_NNS of_IN New_NP York_NP and_CC New_NP Jersey_NP ._SENT Each_DT sample_NN contained_VBD a_DT pool_NN of_IN up_IN to_TO five_CD cloacal_JJ ,_, tracheal_JJ ,_, or_CC environmental_JJ swabs_NNS collected_VBN in_IN 2_CD ml_NN of_IN brain_NN heart_NN infusion_NN broth_NN ._SENT Tracheal_JJ and_CC cloacal_JJ swabs_NNS were_VBD obtained_VBN from_IN up_IN to_TO five_CD birds_NNS of_IN each_DT lot_NN (_( different_JJ birds_NNS of_IN the_DT same_JJ species_NN and_CC from_IN the_DT same_JJ source_NN which_WDT entered_VBD the_DT market_NN at_IN the_DT same_JJ time_NN )_) present_NN at_IN the_DT time_NN the_DT market_NN was_VBD sampled_VBN ,_, except_IN waterfowl_NN ,_, from_IN which_WDT only_JJ cloacal_JJ swabs_NNS were_VBD obtained_VBN ._SENT Five_CD environmental_JJ swabs_NNS were_VBD taken_VBN in_IN the_DT following_VBG areas_NNS in_IN each_DT market_NN :_: the_DT office_NN ,_, bird_NN area_NN ,_, slaughter_NN area_NN ,_, and_CC red_JJ meat_NN area_NN if_IN present_NN ._SENT RNA_NP was_VBD extracted_VBN from_IN each_DT sample_NN as_IN previously_RB described_VBN ._SENT Each_DT sample_NN was_VBD tested_VBN with_IN the_DT influenza_NN virus_NN matrix_NN primer_NN set_VBD ._SENT Samples_NNS positive_JJ with_IN the_DT matrix_NN primer_NN set_NN were_VBD subsequently_RB tested_VBN with_IN the_DT H7-specific_NP primer_NN set_VBD ._SENT Samples_NNS that_WDT were_VBD positive_JJ with_IN the_DT matrix_NN gene_NN primers_NNS and_CC negative_JJ with_IN the_DT H7_JJ primer_NN set_NN were_VBD then_RB tested_VBN with_IN the_DT H5_NP primer_NN set_VBD ._SENT Isolation_NN of_IN influenza_NN virus_NN from_IN swab_NN samples_NNS was_VBD performed_VBN in_IN embryonated_JJ chicken_NN eggs_NNS ._SENT Antibiotics_NNS and_CC antimycotics_NNS were_VBD added_VBN to_TO each_DT sample_NN to_TO the_DT following_VBG final_JJ concentrations_NNS :_: penicillin_NN G_NP ,_, 10,000_CD IU/ml_NN ;_: streptomycin_NN ,_, 2,000_CD mug/ml_NN ;_: gentamicin_NN ,_, 1,000_CD mug/ml_NN ;_: kanamycin_NN ,_, 650_CD mug/ml_NN ;_: amphotericin_NP B_NP ,_, 20_CD mug/ml_NN ._SENT Four_CD 9-_CD to11-day-old_JJ chicken_NN embryos_NNS were_VBD each_DT inoculated_VBN with_IN 300_CD mul_NN of_IN sample_NN with_IN antimicrobials_NNS by_IN the_DT chorioallantoic_JJ sac_NN route_NN ._SENT The_DT eggs_NNS were_VBD incubated_VBN for_IN 4_CD days_NNS and_CC candled_VBD daily_RB for_IN viability_NN ;_: embryos_NNS that_WDT died_VBD within_IN 24_CD h_NN of_IN inoculation_NN were_VBD discarded_VBN as_IN nonspecific_JJ ._SENT CAF_NP from_IN dead_JJ and_CC surviving_VBG embryos_NNS was_VBD tested_VBN for_IN hemagglutination_NN of_IN 0.5_CD %_NN CRBCs_NNS in_IN phosphate-buffered_JJ saline_NN ._SENT Samples_NNS from_IN dead_JJ embryos_NNS that_WDT were_VBD negative_JJ for_IN hemagglutination_NN were_VBD passaged_VBN a_DT second_JJ time_NN ._SENT HA_NP subtypes_NNS of_IN all_DT hemagglutination-positive_JJ samples_NNS were_VBD determined_VBN by_IN hemagglutination_NN inhibition_NN (_( HI_NP )_) assay_NN ._SENT Hemagglutinating_VBG CAF_NP was_VBD standardized_JJ to_TO 4_CD HA_NP units_NNS ,_, and_CC HA_NP was_VBD mixed_VBN with_IN an_DT equal_JJ volume_NN of_IN influenza_NN virus_NN subtype_NN reference_NN serum_NN at_IN a_DT titer_NN between_IN 1:32_CD and_CC 1:64_CD ._SENT Reference_NN serum_NN and_CC CAF_NP were_VBD incubated_VBN for_IN 30_CD min_NN at_IN room_NN temperature_NN ,_, and_CC 0.5_CD %_NN CRBCs_NNS were_VBD added_VBN and_CC mixed_VBN ._SENT The_DT assay_NN was_VBD evaluated_VBN for_IN HI_NP after_IN incubation_NN at_IN room_NN temperature_NN for_IN 30_CD min_NN ._SENT Results_NNS of_IN the_DT RRT-PCR_NP assay_NN were_VBD compiled_VBN with_IN the_DT results_NNS of_IN VI_NP and_CC HI_NP by_IN an_DT independent_JJ third_JJ party_NN to_TO prevent_VB bias_NN ._SENT TABLE_NN 1_CD |_SYM PCR_NP primer_NN and_CC hydrolysis_NN probe_NN sequences_NNS TABLE_NP 6_CD |_SYM Results_NNS of_IN RRT-PCR_NP with_IN type_NN A_DT influenza_NN virus-_NN ,_, H5-_NP ,_, and_CC H7-specific_JJ primer_NN and_CC probe_NN sets_NNS by_IN type_NN A_DT influenza_NN virus_NN isolate_NN and_CC subtype_NN Comparison_NN of_IN RRT-PCR_NP with_IN VI_NP and_CC HI_NP ._SENT |_SYM The_DT sensitivity_NN and_CC specificity_NN of_IN the_DT RRT-PCR_NP assay_NN were_VBD compared_VBN to_TO those_DT of_IN VI_CD in_IN embryonating_JJ eggs_NNS with_IN 1,550_CD clinical_JJ swab_NN samples_NNS from_IN New_NP York_NP and_CC New_NP Jersey_NP live-bird_NN markets_NNS ._SENT Of_IN the_DT swab_NN samples_NNS tested_VBN by_IN both_DT RRT-PCR_NP and_CC VI_NP ,_, 1,183_CD were_VBD negative_JJ by_IN both_DT assays_NNS and_CC 202_CD were_VBD positive_JJ by_IN both_DT assays_NNS ._SENT Overall_RB the_DT results_NNS of_IN the_DT two_CD assays_NNS agreed_VBN on_IN 1,385_CD samples_NNS (_( 89_CD %_NN )_) and_CC disagreed_VBD on_IN 165_CD samples_NNS (_( 11_CD %_NN )_) ._SENT Of_IN the_DT 165_CD samples_NNS on_IN which_WDT results_NNS for_IN the_DT assays_NNS differed_VBD ,_, 101_CD samples_NNS were_VBD positive_JJ by_IN VI_NP and_CC negative_JJ by_IN RRT-PCR_NP ;_: RRT-PCR_NP detected_VBD 202_CD ,_, or_CC 66.6_CD %_NN ,_, of_IN the_DT 303_CD samples_NNS that_WDT were_VBD positive_JJ by_IN VI_NP ._SENT Sixty-four_NP samples_NNS were_VBD positive_JJ by_IN RRT-PCR_NP but_CC negative_JJ by_IN VI_NP ;_: VI_NP detected_VBD 75.6_CD %_NN of_IN the_DT samples_NNS which_WDT were_VBD RRT-PCR_NP positive_NN ._SENT RRT-PCR_NP and_CC VI_NP were_VBD also_RB compared_VBN for_IN their_PP$ relative_JJ sensitivities_NNS and_CC specificities_NNS for_IN the_DT detection_NN of_IN positive_JJ live-bird_NN markets_NNS ._SENT A_DT market_NN was_VBD considered_VBN positive_JJ if_IN at_IN least_JJS one_CD sample_NN was_VBD positive_JJ ._SENT Of_IN the_DT 109_CD live-bird_NN markets_NNS tested_VBN in_IN the_DT study_NN ,_, 37_CD were_VBD negative_JJ by_IN both_DT assays_NNS and_CC 61_CD were_VBD positive_JJ by_IN both_DT assays_NNS ._SENT Overall_RB the_DT assays_NNS agreed_VBD on_IN 98_CD markets_NNS (_( 90_CD %_NN )_) ._SENT Among_IN the_DT markets_NNS with_IN differing_VBG results_NNS ,_, four_CD were_VBD positive_JJ by_IN VI_NP and_CC negative_JJ by_IN RRT-PCR_NP and_CC seven_CD markets_NNS were_VBD positive_JJ by_IN RRT-PCR_NP but_CC negative_JJ by_IN VI_NP ._SENT There_EX was_VBD at_IN least_JJS one_CD RRT-PCR-positive_JJ sample_NN in_IN 61_CD ,_, or_CC 93.8_CD %_NN ,_, of_IN the_DT 65_CD markets_NNS that_WDT were_VBD positive_JJ by_IN VI_NP ._SENT RRT-PCR_NP for_IN H5_NP and_CC H7_NP was_VBD compared_VBN to_TO HI_NP for_IN sensitivity_NN and_CC specificity_NN ._SENT Two_CD hundred_CD two_CD samples_NNS were_VBD tested_VBN for_IN H7_JJ by_IN both_DT HI_NP and_CC RRT-PCR_NP ._SENT There_EX were_VBD four_CD samples_NNS negative_JJ by_IN both_DT assays_NNS ,_, and_CC 194_CD samples_NNS were_VBD positive_JJ by_IN both_DT assays_NNS ;_: results_NNS for_IN 98_CD %_NN of_IN the_DT samples_NNS were_VBD in_IN agreement_NN ._SENT One_CD sample_NN was_VBD positive_JJ by_IN RRT-PCR_NP and_CC negative_JJ by_IN HI_NP ;_: three_CD samples_NNS were_VBD positive_JJ by_IN HI_NP but_CC negative_JJ by_IN RRT-PCR_NP ._SENT Because_IN H5_NP RRT-PCR_NP was_VBD performed_VBN only_RB on_IN samples_NNS that_WDT were_VBD influenza_NN virus_NN positive_JJ and_CC H7_JJ negative_JJ ,_, only_RB eight_CD samples_NNS were_VBD tested_VBN by_IN both_DT methods_NNS ._SENT Both_DT tests_NNS correlated_VBN on_IN all_DT samples_NNS tested_VBN for_IN H5_NP ;_: one_CD sample_NN was_VBD positive_JJ ,_, and_CC seven_CD samples_NNS were_VBD negative_JJ ._SENT The_DT ability_NN of_IN the_DT RRT-PCR_NP assay_NN to_TO detect_VB H5_NP and_CC H7_NP was_VBD also_RB determined_VBN for_IN individual_JJ live-bird_NN markets_NNS ._SENT Both_DT HI_NP and_CC RRT-PCR_NP were_VBD used_VBN to_TO determine_VB the_DT subgroups_NNS of_IN AIV_NP present_NN in_IN 60_CD markets_NNS ;_: 56_CD of_IN the_DT markets_NNS were_VBD positive_JJ by_IN both_DT methods_NNS for_IN the_DT presence_NN of_IN H7_JJ subtype_NN virus_NN ,_, and_CC two_CD markets_NNS were_VBD negative_JJ by_IN both_DT methods_NNS (_( overall_RB 96.6_CD %_NN correlation_NN )_) ._SENT The_DT remaining_VBG two_CD markets_NNS were_VBD positive_JJ for_IN H7_JJ by_IN HI_NP and_CC negative_JJ for_IN H7_JJ by_IN RRT-PCR_NP ._SENT Four_CD markets_NNS were_VBD tested_VBN with_IN both_DT methods_NNS for_IN H5_NP ._SENT Both_DT assays_NNS correlated_VBN for_IN all_DT four_CD markets_NNS ;_: one_CD was_VBD positive_JJ ,_, and_CC three_CD were_VBD negative_JJ ._SENT Assay_NN sensitivity_NN and_CC specificity_NN ._SENT |_SYM The_DT sensitivity_NN of_IN the_DT influenza_NN virus_NN matrix_NN gene_NN ,_, H5_NP ,_, and_CC H7_JJ RRT-PCR_NP assays_NNS relative_JJ to_TO virus_NN titer_NN detectable_JJ by_IN standard_JJ VI_NP in_IN embryonating_JJ eggs_NNS was_VBD determined_VBN ._SENT The_DT detection_NN limit_NN of_IN the_DT matrix_NN gene_NN assay_NN was_VBD determined_VBN to_TO be_VB approximately_RB 10-1_CD 50_CD %_NN egg_NN infective_JJ dose_NN (_( EID50_NP )_) reproducibly_RB by_IN using_VBG the_DT RNA_NP extraction_NN protocol_NN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT The_DT assay_NN could_MD detect_VB RNA_NP from_IN 101_CD EID50s_NNS of_IN H5_NP or_CC H7_NP AIV_NP ._SENT Detection_NN limits_NNS for_IN AIV-_NP and_CC the_DT HA_NP subtype-specific_JJ probe_NN sets_NNS were_VBD determined_VBN by_IN detection_NN of_IN in_IN vitro-transcribed_JJ matrix_NN gene_NN ,_, H5_NP HA_NP gene_NN ,_, or_CC H7_JJ HA_NP gene_NN RNA_NP ._SENT The_DT minimum_JJ copy_NN number_NN of_IN matrix_NN gene_NN RNA_NP which_WDT could_MD be_VB detected_VBN was_VBD approximately_RB 103_CD gene_NN copies_NNS or_CC 10_CD fg_NN of_IN in_IN vitro-transcribed_JJ RNA_NP ._SENT Both_CC the_DT H5_NP and_CC H7_JJ primer_NN sets_NNS had_VBD a_DT reproducible_JJ detection_NN limit_NN of_IN 103_CD to_TO 104_CD gene_NN copies_NNS or_CC approximately_RB 100_CD fg_NN of_IN in_IN vitro-transcribed_JJ RNA_NP ._SENT The_DT matrix_NN gene_NN primer_NN and_CC probe_NN set_NN was_VBD tested_VBN with_IN RNA_NP obtained_VBD from_IN avian-origin_NN influenza_NN virus_NN isolates_VBZ representing_VBG all_DT 15_CD HA_NP subtypes_NNS and_CC isolates_NNS of_IN human_JJ ,_, equine_JJ ,_, and_CC swine_NN origin_NN ._SENT The_DT matrix_NN primer_NN set_NN was_VBD able_JJ to_TO detect_VB all_DT type_NN A_DT influenza_NN viruses_NNS tested_VBD including_VBG viruses_NNS of_IN human_JJ ,_, equine_JJ ,_, and_CC swine_NN origin_NN ._SENT The_DT H5_NP and_CC H7_JJ primer_NN sets_NNS were_VBD tested_VBN with_IN avian-origin_NN isolates_NNS representing_VBG viruses_NNS of_IN each_DT HA_NP subtype_NN ._SENT The_DT H5_NP and_CC H7_JJ primer_NN and_CC probe_NN sets_NNS detected_VBD RNA_NP only_RB from_IN virus_NN isolates_NNS of_IN their_PP$ respective_JJ subtypes_NNS ._SENT Sequencing_NP ._SENT |_SYM Sequencing_NP the_DT matrix_NN genes_NNS of_IN six_CD individual_JJ samples_NNS that_WDT were_VBD VI_CD positive_NN from_IN the_DT live-bird_NN market_NN clinical_JJ samples_NNS but_CC RRT-PCR_NP negative_JJ revealed_VBD no_DT sequence_NN variation_NN in_IN the_DT regions_NNS where_WRB the_DT M+64_NP probe_NN is_VBZ located_VBN ._SENT One_PP isolate_VBP had_VBD a_DT single_JJ base_NN change_NN of_IN an_DT A_NP to_TO a_DT G_NP ,_, which_WDT was_VBD located_VBN at_IN the_DT 5_CD '_POS base_NN of_IN the_DT M+25_NP primer_NN ,_, and_CC there_EX was_VBD also_RB a_DT single_JJ base_NN change_NN of_IN a_DT T_NN to_TO a_DT C_NP at_IN position_NN 7_CD from_IN the_DT 5_CD '_POS end_NN of_IN the_DT M-124_NP primer_NN in_IN all_DT isolates_NNS sequenced_VBD including_VBG the_DT six_CD isolates_NNS which_WDT were_VBD positive_JJ by_IN RRT-PCR_NP during_IN the_DT original_JJ testing_NN ._SENT TABLE_NN 2_CD |_SYM Summary_NN of_IN RRT-PCR_NP and_CC VI_NP results_NNS for_IN individual_JJ samples_NNS from_IN live-bird_NN markets_NNS tested_VBN for_IN type_NN A_DT influenza_NN virus_NN TABLE_NP 3_CD |_SYM Summary_NN of_IN RRT-PCR_NP and_CC VI_NP results_NNS for_IN live-bird_NN markets_NNS tested_VBN for_IN type_NN A_DT influenza_NN virus_NN TABLE_NP 4_CD |_SYM Summary_NN of_IN RRT-PCR_NP and_CC HI_NP results_NNS for_IN individual_JJ samples_NNS from_IN live-bird_NN markets_NNS tested_VBN for_IN the_DT H7_NP or_CC H5_NP HA_NP subtype_NN TABLE_NP 5_CD |_SYM Summary_NN of_IN RRT-PCR_NP and_CC HI_NP results_NNS for_IN live-bird_NN markets_NNS tested_VBN for_IN type_NN A_DT influenza_NN virus_NN and_CC the_DT H7_NP or_CC H5_NP HA_NP subtype_NN Because_IN mildly_RB pathogenic_JJ AIV_NP infection_NN does_VBZ not_RB cause_VB any_DT pathognomonic_JJ clinical_JJ signs_NNS and_CC is_VBZ commonly_RB subclinical_JJ ,_, the_DT presence_NN of_IN the_DT virus_NN must_MD be_VB determined_VBN by_IN a_DT diagnostic_JJ test_NN ._SENT We_PP have_VBP developed_VBN RRT-PCR_NP as_IN a_DT rapid_JJ alternative_NN to_TO VI_NP for_IN AIV_NP detection_NN and_CC subtyping_NN ._SENT In_IN addition_NN to_TO its_PP$ speed_NN ,_, RRT-PCR_NP reduces_VBZ the_DT handling_NN of_IN infectious_JJ material_NN compared_VBN to_TO VI_CD ._SENT RRT-PCR_NP also_RB offers_VBZ several_JJ advantages_NNS over_IN standard_JJ RT-PCR_NP such_JJ as_IN speed_NN and_CC elimination_NN of_IN the_DT possibility_NN of_IN cross-contamination_NN of_IN new_JJ samples_NNS with_IN previously_RB amplified_VBN products_NNS because_IN the_DT sample_NN tube_NN is_VBZ never_RB opened_VBN after_IN PCR_NP ._SENT Additionally_RB ,_, because_IN the_DT RRT-PCR_NP product_NN is_VBZ detected_VBN with_IN a_DT sequence-specific_JJ probe_NN ,_, there_EX is_VBZ confirmation_NN that_IN the_DT correct_JJ target_NN was_VBD amplified_VBN ,_, reducing_VBG the_DT chances_NNS for_IN false_JJ positives_NNS ._SENT The_DT RRT-PCR_NP assay_NN for_IN AIV_NP was_VBD developed_VBN to_TO be_VB a_DT rapid_JJ screening_NN tool_NN for_IN commercial_NN flocks_VBZ and_CC live-bird_NN markets_NNS ._SENT Importantly_RB ,_, in_IN this_DT study_NN ,_, results_NNS could_MD be_VB obtained_VBN quickly_RB ;_: 28_CD clinical_JJ samples_NNS could_MD be_VB processed_VBN and_CC tested_VBN in_IN approximately_RB 3_CD h._NN The_DT assay_NN also_RB performed_VBD well_RB compared_VBN to_TO VI_NP and_CC HI_NP since_IN 94_CD %_NN of_IN the_DT VI-positive_JJ markets_NNS were_VBD also_RB positive_JJ by_IN RRT-PCR_NP and_CC 97_CD %_NN of_IN the_DT markets_NNS that_WDT were_VBD H7_JJ positive_NN by_IN HI_NP were_VBD H7_JJ positive_NN by_IN RRT-PCR_NP ._SENT However_RB ,_, RRT-PCR_NP did_VBD not_RB correlate_VB as_RB well_RB with_IN VI_CD by_IN individual_JJ sample_NN tube_NN ,_, as_RB 11_CD %_NN of_IN the_DT samples_NNS were_VBD positive_JJ by_IN only_RB one_CD method_NN ._SENT Differences_NNS in_IN the_DT detection_NN of_IN AIV_NP between_IN the_DT assays_NNS can_MD probably_RB be_VB explained_VBN at_IN least_JJS in_IN part_NN by_IN what_WP the_DT assays_NNS are_VBP detecting_VBG ._SENT VI_NP can_MD detect_VB only_RB live_JJ virus_NN ,_, and_CC virus_NN that_WDT has_VBZ been_VBN inactivated_VBN during_IN shipping_NN or_CC by_IN disinfectants_NNS (_( which_WDT may_MD be_VB present_JJ in_IN environmental_JJ samples_NNS )_) will_MD not_RB be_VB detected_VBN ,_, whereas_IN they_PP may_MD potentially_RB be_VB detected_VBN by_IN RRT-PCR_NP ._SENT Additionally_RB ,_, all_DT influenza_NN viruses_NNS may_MD not_RB readily_RB adapt_VB to_TO growth_NN to_TO detectable_JJ titers_NNS in_IN embryonating_JJ chicken_NN eggs_NNS within_IN two_CD passages_NNS ._SENT This_DT may_MD explain_VB why_WRB some_DT samples_NNS were_VBD RRT-PCR_NP positive_JJ and_CC VI_CD negative_JJ ._SENT Interestingly_RB ,_, 26_CD of_IN 64_CD (_( 40.6_CD %_NN )_) RRT-PCR-positive_NP ,_, VI-negative_JJ samples_NNS were_VBD classified_VBN as_IN non-H7_NP and_CC non-H5_NP subtype_NN isolates_NNS ._SENT Factors_NNS that_WDT may_MD adversely_RB affect_VB the_DT sensitivity_NN of_IN the_DT RRT-PCR_NP assay_NN versus_IN VI_NP include_VBP RT-PCR-inhibitory_JJ substances_NNS in_IN the_DT samples_NNS ,_, the_DT use_NN of_IN a_DT one-step_NN RT-PCR_NP method_NN ,_, inefficient_JJ RNA_NP extraction_NN procedures_NNS ,_, and_CC the_DT potential_NN for_IN RNA_NP to_TO rapidly_RB degrade_VB before_IN testing_NN ._SENT Importantly_RB ,_, this_DT RRT-PCR_NP test_NN was_VBD designed_VBN to_TO balance_VB both_DT sensitivity_NN and_CC ease_VB of_IN use_NN so_RB that_IN the_DT procedure_NN could_MD be_VB performed_VBN rapidly_RB and_CC on_IN a_DT large_JJ scale_NN ._SENT Therefore_RB ,_, a_DT single-step_VBP RT-PCR_NP was_VBD used_VBN ,_, although_IN this_DT method_NN is_VBZ reported_VBN to_TO be_VB less_RBR sensitive_JJ than_IN a_DT two-step_JJ RT-PCR_NP procedure_NN ._SENT A_DT single-step_VBP RT-PCR_NP procedure_NN also_RB greatly_RB reduces_VBZ the_DT risk_NN of_IN cross_NN contamination_NN because_IN the_DT tubes_NNS are_VBP not_RB reopened_VBN once_IN the_DT template_NN is_VBZ added_VBN ._SENT Additionally_RB ,_, VI_NP tests_NNS use_VBP an_DT equivalent_NN of_IN nine_CD times_NNS more_JJR volume_NN of_IN the_DT original_JJ sample_NN than_IN is_VBZ used_VBN for_IN RRT-PCR_NP ;_: therefore_RB it_PP is_VBZ possible_JJ that_IN alternative_JJ RNA_NP extraction_NN methods_NNS utilizing_VBG a_DT greater_JJR sample_NN volume_NN would_MD increase_VB the_DT sensitivity_NN for_IN samples_NNS with_IN a_DT low_JJ virus_NN titer_NN ._SENT Finally_RB ,_, RNA_NP is_VBZ relatively_RB unstable_JJ and_CC RNA-degrading_JJ enzymes_NNS are_VBP ubiquitous_JJ ;_: therefore_RB the_DT RNA_NP may_MD have_VB been_VBN degraded_VBN prior_RB to_TO testing_NN ,_, although_IN efforts_NNS were_VBD made_VBN to_TO reduce_VB this_DT possibility_NN ._SENT Sequence_NN variation_NN in_IN the_DT matrix_NN gene_NN may_MD also_RB explain_VB why_WRB the_DT RRT-PCR_NP test_NN failed_VBD to_TO detect_VB viral_JJ RNA_NP in_IN some_DT of_IN the_DT virus-positive_JJ samples_NNS ._SENT However_RB matrix_NN gene_NN sequences_NNS from_IN several_JJ samples_NNS that_WDT were_VBD positive_JJ by_IN VI_NP but_CC negative_JJ by_IN RRT-PCR_NP did_VBD not_RB have_VB any_DT sequence_NN variation_NN in_IN the_DT probe_NN binding_VBG region_NN ,_, and_CC the_DT single_JJ base_NN change_NN present_JJ in_IN the_DT M-124_NP primer_NN is_VBZ present_JJ in_IN many_JJ other_JJ isolates_NNS that_WDT were_VBD detected_VBN with_IN these_DT primers_NNS ,_, including_VBG six_CD RRT-PCR-positive_JJ samples_NNS from_IN the_DT same_JJ study_NN ._SENT The_DT 5_CD '_POS base_NN change_NN in_IN one_CD isolate_NN in_IN the_DT M+25_NP primer_NN binding_VBG region_NN is_VBZ also_RB probably_RB not_RB adequate_JJ to_TO prevent_VB primer_JJR binding_NN ._SENT In_IN general_NN ,_, the_DT region_NN of_IN the_DT matrix_NN gene_NN to_TO which_WDT the_DT primers_NNS and_CC probe_NN are_VBP directed_VBN is_VBZ conserved_VBN among_IN type_NN A_DT influenza_NN viruses_NNS ;_: therefore_RB this_DT assay_NN should_MD detect_VB most_RBS ,_, if_IN not_RB all_RB ,_, type_NN A_DT influenza_NN viruses_NNS ,_, as_RB demonstrated_VBN by_IN the_DT detection_NN of_IN nonavian_JJ isolates_NNS with_IN this_DT primer_NN and_CC probe_NN set_NN ._SENT Correlation_NN between_IN the_DT assays_NNS was_VBD better_JJR with_IN H7_NP and_CC H5_NP ,_, although_IN few_JJ samples_NNS were_VBD tested_VBN for_IN H5_NP and_CC H7_JJ ,_, and_CC only_JJ samples_NNS that_WDT were_VBD positive_JJ for_IN influenza_NN virus_NN by_IN both_DT tests_NNS can_MD be_VB compared_VBN ._SENT For_IN example_NN ,_, it_PP is_VBZ not_RB known_VBN if_IN a_DT sample_NN which_WDT was_VBD positive_JJ by_IN VI_NP and_CC H7_NP HI_NP would_MD have_VB been_VBN positive_JJ by_IN the_DT H7_JJ RRT-PCR_NP ,_, although_IN it_PP was_VBD negative_JJ by_IN the_DT influenza_NN virus_NN matrix_NN gene_NN RRT-PCR_NP test_NN ._SENT Although_IN the_DT H5_NP test_NN detected_VBD all_RB of_IN the_DT North_NP American_NP avian-lineage_NP H5_NP isolates_VBZ tested_VBN ,_, too_RB few_JJ clinical_JJ samples_NNS were_VBD tested_VBN to_TO definitively_RB validate_VB the_DT H5_NP RRT-PCR_NP test_NN versus_IN HI_NP ._SENT A_DT comparison_NN of_IN EID50_NP with_IN RRT-PCR_NP indicated_VBD that_IN the_DT matrix_NN gene_NN primer_NN and_CC probe_NN set_NN was_VBD able_JJ to_TO detect_VB 10-1_CD EID50_NN of_IN virus_NN ._SENT The_DT increased_VBN sensitivity_NN of_IN the_DT matrix_NN gene_NN RRT-PCR_NP versus_CC EID50_NP may_MD be_VB due_JJ to_TO the_DT ability_NN of_IN the_DT RRT-PCR_NP assay_NN to_TO detect_VB fewer_JJR virions_NNS than_IN the_DT minimum_NN necessary_JJ to_TO cause_VB hemagglutination_NN ._SENT RRT-PCR_NP is_VBZ also_RB expected_VBN to_TO detect_VB noninfectious_JJ particles_NNS ,_, which_WDT have_VBP been_VBN estimated_VBN to_TO constitute_VB as_RB much_RB as_IN 90_CD %_NN of_IN some_DT virus_NN preparations_NNS ._SENT It_PP is_VBZ unclear_JJ why_WRB increased_VBN sensitivity_NN relative_JJ to_TO EID50_NP was_VBD not_RB observed_VBN with_IN the_DT H5-_NP and_CC H7-specific_NP assays_NNS ._SENT We_PP have_VBP developed_VBN an_DT RRT-PCR_NP assay_NN for_IN the_DT detection_NN of_IN type_NN A_DT influenza_NN virus_NN and_CC the_DT avian_JJ H5_NP and_CC H7_NP HA_NP subtypes_NNS ._SENT RRT-PCR_NP is_VBZ less_RBR expensive_JJ than_IN VI_CD ,_, and_CC ,_, importantly_RB ,_, results_NNS are_VBP available_JJ much_RB faster_RBR ._SENT This_DT assay_NN provides_VBZ a_DT rapid_JJ and_CC feasible_JJ alternative_NN to_TO VI_CD in_IN embryonating_JJ chicken_NN eggs_NNS and_CC subtyping_NN by_IN HI_NP as_IN a_DT flock_NN or_CC live-bird_NN market_NN screening_NN tool_NN ._SENT 